Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Xyrem reduces narcolepsy-associated cataplexy and EDS in the clinic

Jan. 20, 2000

Beta-sheet breaker peptides: new hope for rare but devastating neurodegenerative diseases

Jan. 20, 2000

Hyperforin acetate: stable hyperforin derivative with superior pharmacological activity

Jan. 20, 2000

Sepracor initiates large-scale study of (+)-zopiclone

Jan. 20, 2000

Novel rotamase inhibitors with neurotrophic activity in development at BMS

Jan. 20, 2000

Ampakines increase neurotrophin expression in rats and mice

Jan. 20, 2000

Glycine-antagonist tetrahydroquinoline derivatives designed at Glaxo Wellcome

Jan. 19, 2000

SB discloses newest selective dopamine D3 receptor ligands

Jan. 19, 2000

New beta-carbolines are somatostatin receptor ligands and sodium channel blockers

Jan. 19, 2000

Provigil under study for several indications

Jan. 19, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.